Clinical Trial Update: Aura Adolescent PK Study GSK2829332 [Phase 2]

View source ↗

Summary

The Aura Adolescent PK Study GSK2829332 (Phase 2) in asthma has been withdrawn from the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2829332

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: WITHDRAWN